Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 17, 2021

SELL
$75.39 - $82.36 $6.32 Million - $6.91 Million
-83,896 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$78.33 - $90.73 $3.51 Million - $4.06 Million
44,763 Added 114.39%
83,896 $6.75 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $325,809 - $389,927
-4,142 Reduced 9.57%
39,133 $3.37 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $670,038 - $873,474
-9,362 Reduced 17.79%
43,275 $3.51 Million
Q4 2019

Feb 12, 2020

SELL
$76.7 - $88.45 $9,587 - $11,056
-125 Reduced 0.24%
52,637 $4.4 Million
Q3 2019

Nov 13, 2019

BUY
$81.4 - $89.78 $2.18 Million - $2.41 Million
26,793 Added 103.17%
52,762 $4.62 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $2.4 Million - $2.7 Million
-32,747 Reduced 55.77%
25,969 $2.13 Million
Q1 2019

May 16, 2019

SELL
$64.48 - $81.31 $1.68 Million - $2.12 Million
-26,055 Reduced 30.74%
58,716 $4.77 Million
Q4 2018

Feb 14, 2019

SELL
$61.45 - $77.8 $4.63 Million - $5.86 Million
-75,332 Reduced 47.05%
84,771 $5.58 Million
Q3 2018

Nov 15, 2018

SELL
$70.71 - $77.75 $520,072 - $571,851
-7,355 Reduced 4.39%
160,103 $12.3 Million
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $2.53 Million - $3.01 Million
-39,864 Reduced 19.23%
167,458 $12.4 Million
Q1 2018

May 16, 2018

SELL
$62.56 - $72.26 $1.43 Million - $1.65 Million
-22,881 Reduced 9.94%
207,322 $13.5 Million
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $456,512 - $490,685
-7,429 Reduced 3.13%
230,203 $14.9 Million
Q3 2017

Nov 07, 2017

BUY
$59.5 - $64.61 $14.1 Million - $15.4 Million
237,632
237,632 $14.9 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Kiwi Wealth Investments Limited Partnership Portfolio

Follow Kiwi Wealth Investments Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.